source
- US HHS and FDA announce new rules to expand non-animal testing methods as legal battles over youth gender-affirming care continueThe legal landscape for youth gender‑affirming care remains turbulent, with the Trump administration's aggressive stance prompting dozens of hospitals nationwide to halt such services, even in the…
- FDA shift sparks renewed pharma and VC focus on osteoporosis drug developmentThe FDA recently altered its regulatory framework for osteoporosis medicines, prompting a wave of renewed interest across the pharmaceutical sector. Earlier, drugs from Eli Lilly, Merck, Novartis…